Showing results (1-10 of 60) with videos related to
Sort By:
Pageof 6
Clinical Drug Investigation|March 17, 2017
Complete Tumor Response with Afatinib 20 mg Daily in EGFR-Mutated Non-small Cell Lung Cancer: A Case ReportRaffaele Giusti, Marco Mazzotta, Daniela Iacono, et al.Case Reports in Oncological Medicine|February 24, 2016
Pulmonary Fibrosis after Pegylated Liposomal Doxorubicin in Elderly Patient with Cutaneous AngiosarcomaMarco Mazzotta, Raffaele Giusti, Daniela Iacono, et al.British Journal of Pain|July 31, 2018
The use of fentanyl in pain management in head and neck cancer patients: a narrative reviewRaffaele Giusti, Paolo Bossi, Marco Mazzotta, et al.Cancer Management and Research|March 31, 2022
Patients' Satisfaction with Breakthrough Cancer Pain Therapy: A Secondary Analysis of IOPS-MS StudyMarco Mazzotta, Marco Filetti, Marta Piras, et al.Medicine|August 7, 2020
Case report: 5-year progression free survival and complete liver response in a patient with metastatic breast cancer treated with everolimus plus exemestaneEriseld Krasniqi, Giacomo Barchiesi, Marco Mazzotta, et al.International Journal of Medical Sciences|April 16, 2021
Burnout of health care providers during the COVID-19 pandemic: Focus on Medical OncologistsPatrizia Vici, Eriseld Krasniqi, Laura Pizzuti, et al.Journal of Clinical Medicine|February 21, 2019
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast CancerMarco Mazzotta, Eriseld Krasniqi, Giacomo Barchiesi, et al.Anti-Cancer Drugs|January 11, 2019
Four lines of anaplastic lymphoma kinase inhibitors and brain radiotherapy in a long-surviving non-small-cell lung cancer anaplastic lymphoma kinase-positive patient with leptomeningeal carcinomatosisConcetta E Onesti, Daniela Iacono, Silvia Angelini, et al.Alcohol and Alcoholism (Oxford, Oxfordshire)|September 28, 2018
The Incidence of Alcoholism in Patients with Advanced Cancer Receiving Active Treatment in Two Tertiary Care Centers in ItalyRaffaele Giusti, Marco Mazzotta, Lucilla Verna, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 30, 2022
KEAP1-Mutant NSCLC: The Catastrophic Failure of a Cell-Protecting HubStefano Scalera, Marco Mazzotta, Clelia Cortile, et al.Pageof 6